pubmed-article:21364414 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:21364414 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
pubmed-article:21364414 | lifeskim:mentions | umls-concept:C0039508 | lld:lifeskim |
pubmed-article:21364414 | lifeskim:mentions | umls-concept:C0596171 | lld:lifeskim |
pubmed-article:21364414 | lifeskim:mentions | umls-concept:C0030968 | lld:lifeskim |
pubmed-article:21364414 | lifeskim:mentions | umls-concept:C0030011 | lld:lifeskim |
pubmed-article:21364414 | lifeskim:mentions | umls-concept:C0694754 | lld:lifeskim |
pubmed-article:21364414 | lifeskim:mentions | umls-concept:C2349975 | lld:lifeskim |
pubmed-article:21364414 | lifeskim:mentions | umls-concept:C2698650 | lld:lifeskim |
pubmed-article:21364414 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:21364414 | pubmed:dateCreated | 2011-3-2 | lld:pubmed |
pubmed-article:21364414 | pubmed:abstractText | Tissue engineering of human flexor tendons combines tendon scaffolds with recipient cells to create complete cell-tendon constructs. Allogenic acellularized human flexor tendon has been shown to be a useful natural scaffold. However, there is difficulty repopulating acellularized tendon with recipient cells, as cell penetration is restricted by a tightly woven tendon matrix. The authors evaluated peracetic acid treatment in optimizing intratendinous cell penetration. | lld:pubmed |
pubmed-article:21364414 | pubmed:language | eng | lld:pubmed |
pubmed-article:21364414 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21364414 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:21364414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21364414 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:21364414 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:21364414 | pubmed:month | Mar | lld:pubmed |
pubmed-article:21364414 | pubmed:issn | 1529-4242 | lld:pubmed |
pubmed-article:21364414 | pubmed:author | pubmed-author:ChangJamesJ | lld:pubmed |
pubmed-article:21364414 | pubmed:author | pubmed-author:PhamHungH | lld:pubmed |
pubmed-article:21364414 | pubmed:author | pubmed-author:KrausArminA | lld:pubmed |
pubmed-article:21364414 | pubmed:author | pubmed-author:WoonColin Y... | lld:pubmed |
pubmed-article:21364414 | pubmed:author | pubmed-author:PridgenBrian... | lld:pubmed |
pubmed-article:21364414 | pubmed:author | pubmed-author:BariSinaS | lld:pubmed |
pubmed-article:21364414 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:21364414 | pubmed:volume | 127 | lld:pubmed |
pubmed-article:21364414 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:21364414 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:21364414 | pubmed:pagination | 1107-17 | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:meshHeading | pubmed-meshheading:21364414... | lld:pubmed |
pubmed-article:21364414 | pubmed:year | 2011 | lld:pubmed |
pubmed-article:21364414 | pubmed:articleTitle | Optimization of human tendon tissue engineering: peracetic acid oxidation for enhanced reseeding of acellularized intrasynovial tendon. | lld:pubmed |
pubmed-article:21364414 | pubmed:affiliation | Division of Plastic and Reconstructive Surgery, Stanford University Medical Center, Palo Alto, Calif. 94305, USA. | lld:pubmed |
pubmed-article:21364414 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:21364414 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:21364414 | pubmed:publicationType | Research Support, U.S. Gov't, Non-P.H.S. | lld:pubmed |